Empower Advisory Group LLC purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,439 shares of the medical equipment provider’s stock, valued at approximately $365,000.
Other hedge funds have also recently modified their holdings of the company. HHM Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 1,314.3% in the 1st quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 92 shares during the period. Bogart Wealth LLC lifted its position in Intuitive Surgical by 721.4% during the first quarter. Bogart Wealth LLC now owns 115 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 101 shares during the last quarter. Barrett & Company Inc. purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $30,000. Strategic Investment Solutions Inc. IL purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $39,000. Finally, Addison Advisors LLC lifted its position in Intuitive Surgical by 1,837.5% during the first quarter. Addison Advisors LLC now owns 155 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 147 shares during the last quarter. Hedge funds and other institutional investors own 82.91% of the company’s stock.
Intuitive Surgical Stock Performance
ISRG stock opened at $295.54 on Friday. The firm has a market cap of $103.85 billion, a PE ratio of 74.07, a P/E/G ratio of 4.25 and a beta of 1.30. The firm’s fifty day moving average is $314.56 and its 200 day moving average is $297.57. Intuitive Surgical, Inc. has a one year low of $180.07 and a one year high of $358.07.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on ISRG shares. TheStreet raised shares of Intuitive Surgical from a “c+” rating to a “b” rating in a research report on Monday, July 24th. Raymond James increased their target price on shares of Intuitive Surgical from $323.00 to $368.00 and gave the company an “outperform” rating in a research report on Monday, July 24th. Mizuho raised their price target on shares of Intuitive Surgical from $300.00 to $370.00 in a report on Monday, July 17th. StockNews.com assumed coverage on shares of Intuitive Surgical in a report on Thursday, August 17th. They issued a “buy” rating for the company. Finally, JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $335.00 to $365.00 and gave the stock an “overweight” rating in a report on Friday, July 21st. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $343.10.
Read Our Latest Research Report on Intuitive Surgical
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 2,535 shares of the stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $323.26, for a total transaction of $819,464.10. Following the transaction, the executive vice president now directly owns 7,259 shares of the company’s stock, valued at $2,346,544.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $305.68, for a total transaction of $152,840.00. Following the transaction, the director now directly owns 702 shares of the company’s stock, valued at $214,587.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 2,535 shares of the stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $323.26, for a total transaction of $819,464.10. Following the transaction, the executive vice president now directly owns 7,259 shares in the company, valued at $2,346,544.34. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 60,309 shares of company stock worth $19,649,321. 0.90% of the stock is owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- The 3 Best Blue-Chip Stocks to Buy Now
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- Investing in Agriculture 101: How to Invest in Agriculture
- MarketBeat Week in Review – 9/11 – 9/15
- Stocks in the Dow: About the Dow Jones Industrial Average (DJIA)
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
